Alcon Inc. receives approval for innovative intraocular lens, achieving high light utilization

Alcon Inc. (NYSE: ALC) announces approval of Clareon PanOptix Pro intraocular lens, with proprietary ENLIGHTEN NXT Optical technology achieving 94% light utilization, highest reported for any trifocal intraocular lens. Available in Canada by early 2026. Alcon Inc. (NYSE: ALC) operates in Surgical Business and Vision Care Business segments, offering a range of eye care products.

Read more at Yahoo Finance: Alcon Inc (ALC) Announces Approval of Clareon PanOptix Pro Intraocular Lens